KRAS Gene Cardiofaciocutaneous Syndrome NGS Genetic DNA Test
Comprehensive Genetic Testing for Cardiovascular Disorders
The KRAS Gene Cardiofaciocutaneous Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare cardiovascular and developmental disorders. This advanced testing methodology provides precise detection of mutations in the KRAS gene, which plays a critical role in the RAS/MAPK signaling pathway essential for normal cellular growth and development.
What This Test Measures and Detects
Our comprehensive NGS-based genetic analysis specifically targets:
- Pathogenic variants in the KRAS gene associated with Cardiofaciocutaneous syndrome
- Specific mutations affecting the RAS/MAPK signaling pathway
- Genetic variations responsible for multisystem developmental disorders
- Hereditary patterns of cardiovascular and cutaneous abnormalities
Who Should Consider This Genetic Test
This test is particularly recommended for individuals presenting with:
- Congenital heart defects including pulmonic stenosis and hypertrophic cardiomyopathy
- Distinctive facial features such as high forehead, downslanting palpebral fissures, and low-set ears
- Developmental delays and intellectual disability
- Cutaneous abnormalities including hyperkeratosis and ichthyosis
- Growth retardation and feeding difficulties in infancy
- Family history of similar cardiovascular and developmental concerns
Significant Benefits of KRAS Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out Cardiofaciocutaneous syndrome with high precision
- Personalized Treatment: Enables targeted management strategies for cardiovascular and developmental issues
- Genetic Counseling: Provides essential information for family planning and recurrence risk assessment
- Early Intervention: Facilitates timely medical interventions and specialized care planning
- Comprehensive Care: Supports multidisciplinary approach involving cardiologists, geneticists, and developmental specialists
Understanding Your Test Results
Our genetic counseling team provides comprehensive interpretation of your results:
- Positive Result: Indicates the presence of a pathogenic KRAS mutation, confirming CFC syndrome diagnosis
- Negative Result: Suggests absence of detectable KRAS mutations, though other genetic causes may be considered
- Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
- Carrier Status: Determines inheritance patterns and recurrence risks for family members
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our state-of-the-art genetic testing facilities ensure consistent, high-quality results regardless of your location.
Take the Next Step Toward Genetic Clarity
Don’t let uncertainty about genetic conditions affect your health decisions. Our KRAS Gene Cardiofaciocutaneous Syndrome NGS Genetic DNA Test provides the definitive answers you need for informed medical management and family planning.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling specialists.
With a turnaround time of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, we make genetic testing accessible and convenient for patients throughout the United States.
